News

A novel protein-based antiviral nasal spray designed to treat COVID-19 is set to begin Phase 1 human clinical trials.

A study has shown that it is possible to make methane-consuming bacteria generate power in the lab.

Researchers have discovered that combination therapy of antibodies and dexamethasone may be more effective than giving each treatment in isolation.

Researchers examined how pasta swells, softens and becomes sticky as it takes up water and the role salt plays, combining measurements to form a theoretical model for the swelling dynamics and perfectly cooked pasta.

New research has shown that prior infection with common coronaviruses does not produce protective antibodies against SARS-CoV-2, despite the viruses having significant sequence similarity.

Researchers have demonstrated that some plant species could help to remove toxic heavy metals and metalloids from contaminated soil.

A new drug called valbenazine has proven beneficial in treating a movement disorder commonly associated with Huntington’s disease, according to a recent international study led by UTHealth Houston researcher Erin Furr Stimming, MD.

Researchers have discovered that tumors disrupt the metabolism of fats and proteins to produce methylmalonic acid which drives the cancer cells to metastasize.

A study suggests that drugs already targeting noradrenaline for other diseases may be useful in treating alcohol use disorder.

Scientists have developed a promising new method to combat the age-related losses in muscle mass that often accompany immobility after injury or illness. Their technique, demonstrated in mice, arrests the process by which muscles begin to deteriorate at the onset of exercise after a period of inactivity.